NASDAQ:MDSOMedidata Solutions Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medidata Solutions Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range$91.79MA: $92.20▼$92.2552-Week Range N/AVolume7.30 million shsAverage Volume1.24 million shsMarket Capitalization$5.76 billionP/E Ratio96.06Dividend YieldN/ABeta1.22 ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company was founded in 1999 and is headquartered in New York, New York.Read More Beat the Market (BTM) Rank™ 3.0 Analyst's Opinion Consensus RatingMedidata Solutions has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 6 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $92.25, Medidata Solutions has a potential upside of ∞ from its current price of $0.00.Amount of Analyst CoverageMedidata Solutions has received no research coverage in the past 90 days. Previous Next 2.7 Community Rank Outperform VotesMedidata Solutions has received 506 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMedidata Solutions has received 423 “underperform” votes. (Add your “underperform” vote.)Community SentimentMedidata Solutions has received 54.47% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote “Outperform” if you believe MDSO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMedidata Solutions does not currently pay a dividend.Dividend GrowthMedidata Solutions does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medidata Solutions insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.70% of the stock of Medidata Solutions is held by insiders.Percentage Held by Institutions93.30% of the stock of Medidata Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Medidata Solutions are expected to grow by 29.49% in the coming year, from $0.78 to $1.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medidata Solutions is 96.06, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.13.Price to Earnings Ratio vs. SectorThe P/E ratio of Medidata Solutions is 96.06, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.59.Price to Earnings Growth RatioMedidata Solutions has a PEG Ratio of 6.95. PEG Ratios above 1 indicate that a company could be overvalued. Previous Next Analyst Opinion: 3.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.59 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Prepackaged software Sub-IndustryHealth Care Technology SectorMedical Current SymbolNASDAQ:MDSO Previous Symbol CUSIP58471A10 CIK1453814 Webwww.mdsol.com Phone212-918-1800Debt Debt-to-Equity Ratio0.27 Current Ratio2.56 Quick Ratio2.56Price-To-Earnings Trailing P/E Ratio96.06 Forward P/E RatioN/A P/E Growth6.95 Sales & Book Value Annual Sales$635.70 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow54.55 Book Value$10.32 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)$0.96 Net Income$51.92 million Net Margins6.43% Return on Equity8.64% Return on Assets5.73%Miscellaneous Employees1,998 Outstanding Shares62,460,000Market Cap$5.76 billion Next Earnings DateN/A OptionableOptionable Receive MDSO News and Ratings via Email Sign-up to receive the latest news and ratings for MDSO and its competitors with MarketBeat's FREE daily newsletter. Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of Medidata Solutions? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Medidata Solutions. How were Medidata Solutions' earnings last quarter? Medidata Solutions Inc (NASDAQ:MDSO) announced its quarterly earnings data on Monday, July, 22nd. The company reported $0.48 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.17 by $0.31. The company had revenue of $180.50 million for the quarter, compared to the consensus estimate of $179.95 million. Medidata Solutions had a return on equity of 8.64% and a net margin of 6.43%. Medidata Solutions's quarterly revenue was up 15.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.43 EPS. View Medidata Solutions' earnings history. What price target have analysts set for MDSO? 6 Wall Street analysts have issued 1-year target prices for Medidata Solutions' shares. Their forecasts range from $92.25 to $92.25. On average, they anticipate Medidata Solutions' stock price to reach $92.25 in the next twelve months. View analysts' price targets for Medidata Solutions. Has Medidata Solutions been receiving favorable news coverage? News articles about MDSO stock have trended very negative recently, according to InfoTrie. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medidata Solutions earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutMedidata Solutions. Who are some of Medidata Solutions' key competitors? Some companies that are related to Medidata Solutions include Cerner (CERN), Omnicell (OMCL), HMS (HMSY), Cortexyme (CRTX), Allscripts Healthcare Solutions (MDRX), HealthStream (HSTM), Vocera Communications (VCRA) and Computer Programs & Systems (CPSI). View all competitors. What other stocks do shareholders of Medidata Solutions own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), salesforce.com (CRM), Gilead Sciences (GILD), Allergan (AGN), Alibaba Group (BABA), GrubHub (GRUB), IBM (IBM), Western Digital (WDC) and BioMarin Pharmaceutical (BMRN). Who are Medidata Solutions' key executives? Medidata Solutions' management team includes the following people: Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 57)Mr. Glen M. de Vries, Co-Founder, Pres & Director (Age 47)Mr. Rouven Bergmann, Chief Financial Officer (Age 46)Mr. Michael Pray, Exec. VP - Gen. Mang. of Global Sales (Age 53)Ms. Jill Larsen, Exec. VP - HR & Chief HR Officer (Age 46) What is Medidata Solutions' stock symbol? Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO." How big of a company is Medidata Solutions? Medidata Solutions has a market capitalization of $0.00 and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe. What is Medidata Solutions' official website? The official website for Medidata Solutions is www.mdsol.com. How can I contact Medidata Solutions? Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected] This page was last updated on 6/5/2020 by MarketBeat.com Staff
